MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.
Key Laboratory of Reproductive Medicine of Guangdong Province, The First Affiliated Hospital and School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.
Stem Cell Res Ther. 2021 Oct 30;12(1):559. doi: 10.1186/s13287-021-02626-w.
Diabetic cutaneous ulcers (DCU) are a complication of diabetes with diabetic foot ulcers being the most common, and the wounds are difficult to heal, increasing the risk of bacterial infection. Cell-based therapy utilizing mesenchymal stem cells (MSCs) is currently being investigated as a therapeutic avenue for both chronic diabetic ulcers and severe burns. Wharton's jelly mesenchymal stem cell (WJMSC) with PF-127 hydrogel and sodium ascorbyl phosphate (SAP) improved skin wound healing in mice. Whether this combination strategy is helpful to diabetic ulcers wound healing remains to be explored.
Firstly, the WJMSCs embedded in PF-127 and SAP combination were transplanted onto excisional cutaneous wound bed in type 2 diabetic Sprague Dawley (SD) rats. Two weeks after transplantation, the skin tissue was collected for histological and immunohistochemical analysis. Further, overexpressing-EGFP WJMSCs were performed to investigate cell engraftment in the diabetic cutaneous ulcer. The apoptosis of WJMSCs which encapsulated with combination of PF-127 and SAP was detected by TUNEL fluorescence assay and RT-PCR in vitro. And the mitochondrial damage induced by oxidative stress assessed by MitoTracker and CMH2DCFDA fluorescence assay.
In diabetic cutaneous wound rat model, PF-127 plus SAP-encapsulated WJMSCs transplantation promoted diabetic wound healing, indicating improving dermis regeneration and collagen deposition. In diabetic wound healing, less pro-inflammatory M1 macrophages, more anti-inflammatory M2 tissue-healing macrophages, and neovascularization were observed in PF-127 + SAP + WJMSCs group compared with other groups. SAP supplementation alleviated the apoptosis ratio of WJMSCs embedded in the PF-127 in vitro and promoted cell survival in vivo.
PF-127 plus SAP combination facilitates WJMSCs-mediated diabetic wound healing in rat through promoting cell survival, the macrophage transformation, and angiogenesis. Our findings may potentially provide a helpful therapeutic strategy for patients with diabetic cutaneous ulcer.
糖尿病性皮肤溃疡(DCU)是糖尿病的一种并发症,其中糖尿病足溃疡最为常见,且这些伤口难以愈合,增加了细菌感染的风险。利用间充质干细胞(MSCs)的细胞治疗目前正在作为慢性糖尿病溃疡和严重烧伤的一种治疗途径进行研究。含 PF-127 水凝胶和抗坏血酸钠(SAP)的 Wharton 胶间充质干细胞(WJMSC)可改善小鼠皮肤伤口愈合。这种联合策略是否有助于糖尿病溃疡伤口愈合仍有待探索。
首先,将嵌入 PF-127 和 SAP 组合的 WJMSCs 移植到 2 型糖尿病 Sprague Dawley(SD)大鼠的切除性皮肤创面床上。移植后两周,采集皮肤组织进行组织学和免疫组织化学分析。进一步,通过过表达-EGFP WJMSCs 来研究细胞在糖尿病皮肤溃疡中的植入情况。通过 TUNEL 荧光测定法和体外 RT-PCR 检测包封在 PF-127 和 SAP 组合中的 WJMSC 的凋亡。通过 MitoTracker 和 CMH2DCFDA 荧光测定法评估氧化应激诱导的线粒体损伤。
在糖尿病皮肤创面大鼠模型中,PF-127 加 SAP 包封的 WJMSC 移植促进了糖尿病创面愈合,表明真皮再生和胶原沉积得到改善。在糖尿病创面愈合中,与其他组相比,PF-127+SAP+WJMSC 组观察到更少的促炎 M1 巨噬细胞、更多的抗炎 M2 组织修复巨噬细胞和新生血管化。SAP 补充剂减轻了体外 PF-127 包埋的 WJMSC 的凋亡比例,并促进了体内细胞存活。
PF-127 加 SAP 联合促进了 WJMSC 介导的糖尿病大鼠创面愈合,通过促进细胞存活、巨噬细胞转化和血管生成。我们的研究结果可能为糖尿病皮肤溃疡患者提供一种有帮助的治疗策略。